ReviewInternal medicine (Tokyo, Japan)2026
Levofloxacin-Induced Eosinophilic Pneumonia with Systemic Manifestations: A Case Report and Literature Review.
Review in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-induced eosinophilic pneumonia (D-EP) is a rare adverse drug reaction that can rapidly progress to life-threatening respiratory failure without the timely withdrawal of the offending agent. We herein present the case of a 73-year-old man who developed diffuse erythema, dyspnea, and renal impairment 22 days after the initiation of levofloxacin. Laboratory evaluation revealed marked eosinophilia, and chest CT revealed diffuse ground-glass opacities. His respiratory status deteriorated, thus necessitating noninvasive positive pressure ventilation. Discontinuation of levofloxacin and prompt corticosteroid therapy led to the resolution of the skin lesions, an improvement of the renal function, and recovery, thereby allowing for successful discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.